StockData
Sanofi logo

Sanofi

SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026Score 6/30
$46.06−1.06 (-2.25%)

Close on Nov 19, 2026Market cap $112.33BP/E 13.1Yield –

Sanofi Completed Clinical Trials with Publicly Shared Results by Year

Completed Clinical Trials with Publicly Shared Results & Anonymized Data

Sanofi Completed Clinical Trials with Publicly Shared Results: 260 in FY2025, up 10.6% from a year earlier.

Latest, FY2025
260
Period ended Dec 31, 2025
Change on a year earlier
+10.6%
235 in FY2024
History
3 years
Since FY2023
Sources
1
Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS)

Where the FY2025 figure comes from

Source: Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗

Reported in Sanofi CSRD / ESG Key Performance Indicators Workbook.

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCompleted Clinical Trials with Publicly Shared Results & Anonymized DataYear on yearSource
FY2025Dec 31, 2025260+10.6%Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗
FY2024Dec 31, 2024235+15.2%Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗
FY2023Dec 31, 2023204–Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗

Cite this data

StockData. (2026). Sanofi Completed Clinical Trials with Publicly Shared Results, annual FY2023–FY2025 [Data set]. Compiled from Sanofi SEC filings and investor materials. https://stockdatahq.com/stocks/sny/kpis/esg-ct-shared-data

See every metric in the Sanofi KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?